Belanger S., Belleville S., Gauthier S. (2010). Inhibition impairments in Alzheimer's disease, mild cognitive impairment and healthy aging: Effect of congruency proportion in a Stroop task, Neuropsychologia, 48(2), 581-590.

Black S. E., Gauthier S., Dalziel W., Keren R., Correia J., Hew H., Binder C. (2010). Canadian Alzheimer's disease caregiver survey: baby-boomer caregivers and burden of care, Int J Geriatr Psychiatry, 25(8), 807-13. En savoir plus.

Davidson J. E., Irizarry M. C., Bray B. C., Wetten S., Galwey N., Gibson R., Borrie M., Delisle R., Feldman H. H., Hsiung G. Y., Fornazzari L., Gauthier S., Guzman D., Loy-English I., Keren R., Kertesz A., George-Hyslop P. S., Wherrett J., Monsch A. U. (2010). An exploration of cognitive subgroups in Alzheimer's disease, J Int Neuropsychol Soc, 16(2), 233-43.

Desmarais J.E., Gauthier S. (2010). Alzheimer disease: Clinical use of cholinergic drugs in Alzheimer disease, Nat Rev Neurol, 6(8), 418-420.

Gauthier S., Champagne N., Lafreniere R. G., Xiong L., Spiegelman D., Brustein E., Lapointe M., Peng H., Cote M., Noreau A., Hamdan F. F., Addington A. M., Rapoport J. L., Delisi L. E., Krebs M. O., Joober R., Fathalli F., Mouaffak F., Haghighi A. P., Neri C., Dube M. P., Samuels M. E., Marineau C., Stone E. A., Awadalla P., Barker P. A., Carbonetto S., Drapeau P., Rouleau G. A. (2010). De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia, Proc Natl Acad Sci U S A, 107(17), 7863-8.

Gauthier S., Cummings J., Ballard C., Brodaty H., Grossberg G., Robert P., Lyketsos C. (2010). Management of behavioral problems in Alzheimer's disease, Int Psychogeriatr, 22(3), 346-72.

Gauthier S., Garcia A., Sano M., Robert P., Senanarong V., Woodward M., Brodaty H. (2010). Priorities for research consortia on Alzheimer's disease, Alzheimers Dement, 6(4), 359-362.

Gauthier S., Juby A., Dalziel W., Rehel B., Schecter R. (2010). Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE), Curr Med Res Opin, 26(5), 1149-60.

Gauthier S., Leuzy A. (2010). Pre-dementia Diagnosis of Alzheimer’s Disease, Can Rev Alzheimers Dis Other Dement, 13, 15-17.

Gauthier S., Leuzy A. (2010). Diagnosis of prodromal Alzheimer's disease: do you really want to know?, Can J Neurol Sci, 37(1), 2.

Gauthier S., Lopez O.L., Waldemar G., Jones R.W., Cummings J., Zhang R., Schindler R., Schwam E. (2010). Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease, Int Psychogeriatr, 22(6), 973-983.

Massoud F., Gauthier S. (2010). Update on the pharmacological treatment of Alzheimer's disease, Curr Neuropharmacol, 8(1), 69-80. En savoir plus.

Moorhouse P., Song X., Rockwood K., Black S., Kertesz A., Gauthier S., Feldman H. (2010). Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study, J Neurol Sci, 288(1-2), 142-6.

Plosker G. L., Gauthier S. (2010). Spotlight on cerebrolysin in dementia, CNS Drugs, 24(3), 263-6.

Robert P., Ferris S., Gauthier S., Ihl R., Winblad B., Tennigkeit F. (2010). Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?, Alzheimers Res Ther, 2(4), 24. En savoir plus.

de Medeiros K., Robert P., Gauthier S., Stella F., Politis A., Leoutsakos J., Taragano F., Kremer J., Brugnolo A., Porsteinsson A. P., Geda Y. E., Brodaty H., Gazdag G., Cummings J., Lyketsos C. (2010). The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia, Int Psychogeriatr, 22(6), 984-94. En savoir plus.